Showing results (1641-1650 of 6,962) with videos related to

Sort By:
Pageof 697
Journal of Clinical Pharmacology|February 27, 2023
Pharmacokinetics and Safety of Imeglimin in Japanese Patients With Impaired Renal FunctionAtsushi Kitamura, Takuya Yumizaki, Tomoe Kondo, et al.
Journal of Clinical Pharmacology|August 16, 2021
Pharmacologic Similarities and Differences Among HallucinogensKristin Waters
Journal of Clinical Pharmacology|November 28, 2025
Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on DosingNolan Thomas, Matthew W Harer, Sin Yin Lim
Journal of Clinical Pharmacology|December 17, 2025
Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic ExposureSteven Sun, Mina Nikanjam, Mark Mirochnick, et al.
Journal of Clinical Pharmacology|January 14, 2026
No QTcF Prolongation with Sepiapterin: Results From a Thorough QT Study in Healthy Subjects at Therapeutic and Supratherapeutic DosesLan Gao, Hongqi Xue, Borje Darpo, et al.
Journal of Clinical Pharmacology|January 9, 2026
Clinical Outcomes and Patient Profiles in the UK Medical Cannabis Registry: A k-Means Clustering AnalysisSimon Erridge, Evonne Clarke, Katy McLachlan, et al.
Journal of Clinical Pharmacology|July 4, 2025
Development of a Risk Prediction Model for Linezolid-Induced Thrombocytopenia Based on the Machine Learning AlgorithmJie Chi, Juan Wang, Heng Tang, et al.
Journal of Clinical Pharmacology|July 3, 2025
Therapeutic Use of Cannabis Derivatives and Their Analogs for Autism Spectrum Disorder: A Systematic ReviewRachel Riera, Isabela Porto de Toledo, Cecília Menezes Farinasso, et al.
Journal of Clinical Pharmacology|July 3, 2025
Methoxyethyl Etomidate Hydrochloride (ET-26): A Phase I Clinical Trial Assessing Drug-Drug Interactions in Healthy SubjectsFan Yang, Pan-Pan Ye, Wen-Shuo Lv, et al.
Pageof 697